US FDA to amend informed consent requirements
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration has proposed a new rule that, if finalised, would require clinical trial investigators to amend their informed consent documents and processes for drug, biologic and device clinical investigations1.